Initial Workup for Secondary Hypertension
The initial workup for secondary hypertension should include targeted screening tests based on specific clinical clues, with ambulatory blood pressure monitoring, basic laboratory tests, and evaluation for the most common causes including obstructive sleep apnea, primary aldosteronism, and renovascular disease. 1
When to Suspect Secondary Hypertension
Secondary hypertension should be suspected in patients with:
- Abrupt onset or worsening of hypertension
- Age <35 years with significant hypertension (diastolic >110 mmHg)
- New onset hypertension after age 50
- Resistant hypertension requiring multiple medications
- Malignant hypertension with end-organ damage (BP ≥180/110 mmHg)
- Deterioration of renal function with ACE inhibitors/ARBs
- Presence of abdominal bruits
- Generalized arteriosclerotic occlusive disease 1
Initial Diagnostic Algorithm
Step 1: Confirm True Hypertension
- Perform ambulatory blood pressure monitoring to rule out white-coat hypertension 1
- Ensure proper BP measurement technique with appropriate cuff size
Step 2: Basic Laboratory Evaluation
- Complete blood count
- Basic metabolic panel (sodium, potassium, creatinine, BUN, glucose)
- Urinalysis
- Lipid profile
- Thyroid stimulating hormone (TSH)
- Electrocardiogram 1, 2
Step 3: Targeted Screening Based on Clinical Suspicion
| Suspected Cause | Clinical Clues | Recommended Screening Test |
|---|---|---|
| Primary aldosteronism | Hypokalemia, resistant hypertension | Aldosterone-to-renin ratio |
| Renovascular hypertension | Abdominal bruit, deterioration of renal function with ACE inhibitors | Renal Doppler ultrasound, CT/MR angiography |
| Pheochromocytoma | Episodic symptoms (headache, sweating, palpitations) | 24h urinary/plasma metanephrines and normetanephrines |
| Obstructive sleep apnea | Snoring, daytime somnolence, obesity | Overnight polysomnography |
| Renal parenchymal disease | Abnormal urinalysis, elevated creatinine | Renal ultrasound, eGFR |
| Cushing's syndrome | Central obesity, striae, moon facies | 24h urinary free cortisol, dexamethasone suppression |
| Coarctation of aorta | Upper/lower extremity BP difference, delayed femoral pulses | Echocardiogram, CT angiogram [1] |
Prioritizing Evaluation by Prevalence
Obstructive Sleep Apnea: Most prevalent secondary cause, present in up to 83% of patients with resistant hypertension 1
- Screen with validated questionnaires (STOP-BANG, Epworth Sleepiness Scale)
- Refer for polysomnography when score indicates high risk
Primary Aldosteronism: Present in approximately 20% of resistant hypertension cases 1
- Note: Often does not present with hypokalemia in early stages
- Morning aldosterone-to-renin ratio after correcting hypokalemia
- Hold interfering medications (spironolactone, eplerenone) for 4-6 weeks before testing
Renovascular Hypertension: Most common type of secondary hypertension in the general population (0.5-5%) 1
- Renal Doppler ultrasound as initial screening
- CT or MR angiography for definitive diagnosis
Medication-Induced Hypertension: Review all medications and substances
- NSAIDs, oral contraceptives, corticosteroids, decongestants
- Recreational drugs (cocaine, amphetamines)
- Herbal supplements (ephedra, ma huang) 1
Special Considerations
Age-Specific Approach: Secondary causes are more common in children (<6 years) and young adults (<35 years) 1
Resistant Hypertension: Always assess medication adherence before extensive workup
- Consider therapeutic drug monitoring or pill counts
- Evaluate for white-coat effect with ambulatory monitoring 1
Cost-Effective Approach: Target testing based on clinical suspicion rather than universal screening
Pitfalls to Avoid
- Failing to confirm true hypertension before extensive workup
- Overlooking medication non-adherence as a cause of apparent resistant hypertension
- Not considering multiple secondary causes that may coexist
- Ignoring drug-induced causes of secondary hypertension
- Expecting complete normalization of blood pressure after treating secondary cause - many patients have residual essential hypertension 3